Simplex Trading, LLC Tiziana Life Sciences LTD Transaction History

Simplex Trading, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 01, 2023	SELL	$0.6 - $0.82 $172 - $235	-287 Reduced 79.28%	75 $0
Q2 2023 Aug 04, 2023	BUY	$0.65 - $1.29 $235 - $466	362 New	362 $0
Q4 2022 Feb 02, 2023	BUY	$0.56 - $0.69 $260 - $320	465 New	465 $0
Q4 2021 Feb 04, 2022	BUY	$0.89 - $1.66 $323 - $602	363 New	363 $0

816K

Ticker TLSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,273,000
Market Cap $94.1M
Description
Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.